ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2008;86:353-354. doi:10.1016/j.athoracsur.2008.01.025
© 2008 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Frederic W. Grannis, Jr
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grannis, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grannis, F. W., Jr
Related Collections
Right arrow Lung - cancer
Right arrowRelated Article

Correspondence

Is Primary Resection of Stage IIIA Lung Cancer Futile?

Frederic W. Grannis, Jr, MD

Department of Thoracic Surgery, City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA 91010

(Email: fgrannis@coh.org).

The first 20% of the full text of this article appears below.

To the Editor:

Riquet and colleagues [1] report their experience in the primary surgical treatment of 586 patients with N2, stage IIIA, non-small cell lung cancer (NSCLC). Cases include both cN0 with pN2 metastasis after mediastinal node dissection, as well as patients with clinical (cN2) disease, and "bulky" cN2 disease, defined as nodes larger than 2 cm. Their patients had relatively high survival of greater than 30% at 5 years with single station N2 and 20% in patients with "bulky" disease, without preoperative mediastinoscopy, preoperative chemotherapy, or chemoradiation therapy.

But isn't this thoracic surgical heresy?

A Google search on . . . [Full Text of this Article]


Related Article

Reply
Marc Riquet, Patrick Bagan, and Eugenu Banu
Ann. Thorac. Surg. 2008 86: 354. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
F. W. Grannis Jr
Minimal Survival After Chemoradiation Therapy for "Non-Bulky" Stage IIIA NSCLC: What Are the Implications?
Ann. Thorac. Surg., April 1, 2009; 87(4): 1320 - 1320.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. J. Cerfolio
Reply
Ann. Thorac. Surg., April 1, 2009; 87(4): 1320 - 1321.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. Riquet, P. Bagan, and E. Banu
Reply
Ann. Thorac. Surg., July 1, 2008; 86(1): 354 - 354.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.